Atlas Trials

Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia

Clinical trial NCT02964923 · UNKNOWN

Trial details

NCT number
NCT02964923
Sponsor
Xijing Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Schizophrenia
Start date
2016-04-01
Primary completion
2017-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.